132 related articles for article (PubMed ID: 36786292)
1. Public health interventions successfully mitigated multiple incursions of SARS-CoV-2 Delta variant in the Australian Capital Territory.
Hall RN; Jones A; Crean E; Marriott V; Pingault N; Marmor A; Sloan-Gardner T; Kennedy K; Coleman K; Johnston V; Schwessinger B
Epidemiol Infect; 2023 Feb; 151():e30. PubMed ID: 36786292
[TBL] [Abstract][Full Text] [Related]
2. Lessons from a COVID-19 outbreak in the disability support sector, Australian Capital Territory, August 2021.
Phabmixay A; Polkinghorne B; Marmor A; Pingault N; Sloan-Gardner T; Kirk M
Commun Dis Intell (2018); 2023 Jun; 47():. PubMed ID: 37357182
[TBL] [Abstract][Full Text] [Related]
3. Genomics-informed responses in the elimination of COVID-19 in Victoria, Australia: an observational, genomic epidemiological study.
Lane CR; Sherry NL; Porter AF; Duchene S; Horan K; Andersson P; Wilmot M; Turner A; Dougall S; Johnson SA; Sait M; Gonçalves da Silva A; Ballard SA; Hoang T; Stinear TP; Caly L; Sintchenko V; Graham R; McMahon J; Smith D; Leong LE; Meumann EM; Cooley L; Schwessinger B; Rawlinson W; van Hal SJ; Stephens N; Catton M; Looker C; Crouch S; Sutton B; Alpren C; Williamson DA; Seemann T; Howden BP
Lancet Public Health; 2021 Aug; 6(8):e547-e556. PubMed ID: 34252365
[TBL] [Abstract][Full Text] [Related]
4. Integrated genomic surveillance enables tracing of person-to-person SARS-CoV-2 transmission chains during community transmission and reveals extensive onward transmission of travel-imported infections, Germany, June to July 2021.
Houwaart T; Belhaj S; Tawalbeh E; Nagels D; Fröhlich Y; Finzer P; Ciruela P; Sabrià A; Herrero M; Andrés C; Antón A; Benmoumene A; Asskali D; Haidar H; von Dahlen J; Nicolai J; Stiller M; Blum J; Lange C; Adelmann C; Schroer B; Osmers U; Grice C; Kirfel PP; Jomaa H; Strelow D; Hülse L; Pigulla M; Kreuzer P; Tyshaieva A; Weber J; Wienemann T; Kohns Vasconcelos M; Hoffmann K; Lübke N; Hauka S; Andree M; Scholz CJ; Jazmati N; Göbels K; Zotz R; Pfeffer K; Timm J; Ehlkes L; Walker A; Dilthey AT; ;
Euro Surveill; 2022 Oct; 27(43):. PubMed ID: 36305336
[TBL] [Abstract][Full Text] [Related]
5. Vaccine breakthrough infections in a highly-vaccinated Australian population during a SARS-CoV-2 Delta outbreak.
Sheel M; Vun Voo T; Pingault N; Sloan-Gardner TS; Marmor A; Kirk MD; Johnston V; Coleman K
Commun Dis Intell (2018); 2022 Jun; 46():. PubMed ID: 35739073
[TBL] [Abstract][Full Text] [Related]
6. Estimating COVID Risk During a Period of Pandemic Decline.
Inglis TJJ; McFadden B; Macali A
Front Public Health; 2021; 9():744819. PubMed ID: 34976916
[No Abstract] [Full Text] [Related]
7. Opening up safely: public health system requirements for ongoing COVID-19 management based on evaluation of Australia's surveillance system performance.
Lokuge K; D'Onise K; Banks E; Street T; Jantos S; Baptista M; Glass K
BMC Med; 2022 Apr; 20(1):157. PubMed ID: 35421989
[TBL] [Abstract][Full Text] [Related]
8. Pens down: An outbreak of the B.1.617.2 SARS-CoV-2 variant in an Australian high school, August 2021.
Allen K; Marmor A; Pourmarzi D
Commun Dis Intell (2018); 2022 Jul; 46():. PubMed ID: 35860870
[TBL] [Abstract][Full Text] [Related]
9. Genomic epidemiology of Delta SARS-CoV-2 during transition from elimination to suppression in Aotearoa New Zealand.
Jelley L; Douglas J; Ren X; Winter D; McNeill A; Huang S; French N; Welch D; Hadfield J; de Ligt J; Geoghegan JL
Nat Commun; 2022 Jul; 13(1):4035. PubMed ID: 35821124
[TBL] [Abstract][Full Text] [Related]
10. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
11. Unique Genomic Epidemiology of COVID-19 in the White Mountain Apache Tribe, April to August 2020, Arizona.
Bowers JR; Yaglom HD; Hepp CM; Pfeiffer A; Jasso-Selles D; Bratsch N; Nashio JT; Folkerts M; Wilbur SM; French C; Lemmer D; Fitzpatrick K; Huynh T; Komatsu K; McAuley JB; Close R; Engelthaler DM
mSphere; 2023 Apr; 8(2):e0065922. PubMed ID: 36853059
[TBL] [Abstract][Full Text] [Related]
12. Performance of the Swiss Digital Contact-Tracing App Over Various SARS-CoV-2 Pandemic Waves: Repeated Cross-sectional Analyses.
Daniore P; Nittas V; Ballouz T; Menges D; Moser A; Höglinger M; Villiger P; Schmitz-Grosz K; Von Wyl V
JMIR Public Health Surveill; 2022 Nov; 8(11):e41004. PubMed ID: 36219833
[TBL] [Abstract][Full Text] [Related]
13. Outbreak of SARS-CoV-2 B.1.617.2 (Delta Variant) in a Youth Camp Associated With Community Spread, Nebraska, June-July 2021.
Bai JH; Phinney S; Angell K; Grimm B; Tegomoh B; Figliomeni J; Abdalhamid B; Khan AS; Donahue M; Brett-Major DM; McDougall L
Public Health Rep; 2023; 138(1):157-163. PubMed ID: 36113162
[TBL] [Abstract][Full Text] [Related]
14. Revealing COVID-19 transmission in Australia by SARS-CoV-2 genome sequencing and agent-based modeling.
Rockett RJ; Arnott A; Lam C; Sadsad R; Timms V; Gray KA; Eden JS; Chang S; Gall M; Draper J; Sim EM; Bachmann NL; Carter I; Basile K; Byun R; O'Sullivan MV; Chen SC; Maddocks S; Sorrell TC; Dwyer DE; Holmes EC; Kok J; Prokopenko M; Sintchenko V
Nat Med; 2020 Sep; 26(9):1398-1404. PubMed ID: 32647358
[TBL] [Abstract][Full Text] [Related]
15. Using genomic epidemiology of SARS-CoV-2 to support contact tracing and public health surveillance in rural Humboldt County, California.
Stoddard G; Black A; Ayscue P; Lu D; Kamm J; Bhatt K; Chan L; Kistler AL; Batson J; Detweiler A; Tan M; Neff N; DeRisi JL; Corrigan J
BMC Public Health; 2022 Mar; 22(1):456. PubMed ID: 35255849
[TBL] [Abstract][Full Text] [Related]
16. Bondi and beyond. Lessons from three waves of COVID-19 from 2020.
Capon A; Sheppeard V; Gonzalez N; Draper J; Zhu A; Browne M; Sullivan E; Mihajlovic M; Rockett R; Ferson MJ
Public Health Res Pract; 2021 Sep; 31(3):. PubMed ID: 34494077
[TBL] [Abstract][Full Text] [Related]
17. Infection and Transmission of SARS-CoV-2 B.1.617.2 Lineage (Delta Variant) among Fully Vaccinated Individuals.
Caserta LC; Martins M; Cronk B; Anderson R; Eldridge H; Gallow D; Kruppa F; Plocharczyk E; Diel DG
Microbiol Spectr; 2022 Oct; 10(5):e0056322. PubMed ID: 36165775
[TBL] [Abstract][Full Text] [Related]
18. 'They're getting a taste of our world': A qualitative study of people with multiple sclerosis' experiences of accessing health care during the COVID-19 pandemic in the Australian Capital Territory.
Parkinson A; Drew J; Hall Dykgraaf S; Fanning V; Chisholm K; Elisha M; Lueck C; Phillips C; Desborough J
Health Expect; 2021 Oct; 24(5):1607-1617. PubMed ID: 34227728
[TBL] [Abstract][Full Text] [Related]
19. Responding to a school SARS-CoV-2 outbreak: Insights and policy implications emerging from the pandemic.
Marrero MC; Bonfini Petraccone J; Guida S; Montesi A; Fanti A; Gigliola G; Scalingi S; Aucone R; Russo FT; Lovetro D; Facente F; Germini F; Del Prete J; Ierardi T; Zagaria N; Gerbasi G; Brandimarte MA; Parente P; Di Rosa E; Paglione L
Ann Ig; 2023; 35(2):178-187. PubMed ID: 35532051
[TBL] [Abstract][Full Text] [Related]
20. Epidemiological characteristics and transmission dynamics of the outbreak caused by the SARS-CoV-2 Omicron variant in Shanghai, China: a descriptive study.
Chen Z; Deng X; Fang L; Sun K; Wu Y; Che T; Zou J; Cai J; Liu H; Wang Y; Wang T; Tian Y; Zheng N; Yan X; Sun R; Xu X; Zhou X; Ge S; Liang Y; Yi L; Yang J; Zhang J; Ajelli M; Yu H
medRxiv; 2022 Jun; ():. PubMed ID: 35765564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
